(Q37770397)

22 August 2017

title

Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin (English)

1 reference

carcinoma of unknown primary

22 August 2017

main subject

1 reference

John E Musser

1

1 reference

22 August 2017

Christopher G Przybycin

series ordinal

2

1 reference

22 August 2017

Paul Russo

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

6 July 2010

1 reference

22 August 2017

published in

Nature Reviews Urology

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

466-470

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2010.99

22 August 2017

exact match

0 references

cites work

Treatment of stage I seminoma: a 15-year review

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Management of Stage II testicular seminoma over a period of 40 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Introduction: unknown primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Diagnostic and therapeutic management of cancer of an unknown primary

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Testicular Germ Cell Tumours in Denmark 1976–1980 Pathology of 1058 Consecutive Cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Population based incidence and age distribution of spermatocytic seminoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Occult germ-cell testicular tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Burned-out primary testicular cancer: sonographic and pathological characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Comparison of histologic types of primary testicular germ cell tumors with their metastases: consequences for the WHO and the British Nomenclatures?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Spontaneous regression of metastases from testicular tumours a report of six cases from one centre

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Spontaneous regression of retroperitoneal metastases from a primary pure anaplastic seminoma: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Stage II testicular seminoma: patterns of recurrence and outcome of treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.99

Surgery for a post-chemotherapy residual mass in seminoma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20606623

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Spontaneous regression of cancer: possible mechanisms

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20606623

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRUROL.2010.99

1 reference

22 August 2017

1 reference